Cook Islands plants show regenerative properties

A skin care product based on plants used in traditional Cook Islands remedies has been created by UNSW researchers who are also investigating the regenerative properties of the plants for use in wound and bone healing.

The TeTika cosmetics, developed with the company Cimtech's BioActive Cook Islands oil, incorporates traditional Cook Islands medicines.

TeTika means 'truth and integrity' in Cook Islands Maori.

In 2003, Dr Graham Matheson and UNSW Medicine's Professor Bill Walsh began investigating the regenerative properties of plants in partnership with the local traditional leaders.

Dr Matheson, who has completed a PhD at UNSW based on the project, founded a company that permits traditional owners to share in financial benefits from his research, which has received support from UNSW's commercialisation company, NewSouth Innovations. The company was most recently supported by Australia.

"The University and the traditional leaders and I entered into an agreement that is currently being discussed around the world at biodiversity forums as towards world's best practice in access and benefit sharing," Dr Matheson says.

Dr Matheson and Professor Walsh are now investigating that promote new and skin healing. Professor Walsh says research using the plants is a continued collaborative project.

Dr Matheson and UNSW are major shareholders in the company, Cimtech.

More information: tetika.com.au/

add to favorites email to friend print save as pdf

Related Stories

Water wonder

May 13, 2011

A brilliant water saving idea by UNSW engineering academics Greg Leslie and Bruce Sutton has impressed the judges on ABC TV’s New Inventors program.

Saltwater solution to save crops

Sep 11, 2008

Technology under development at the University of New South Wales could offer new hope to farmers in drought-affected and marginal areas by enabling crops to grow using salty groundwater.

Recommended for you

Using computers to design drugs

12 hours ago

Designing a new medicine is an expensive and time consuming business. Typically it takes around $2 billion and ten years for a new drug to move from its initial design in the lab, to the clinic. All the ...

Lilly psoriasis drug fares well in late-stage test

17 hours ago

Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

New US restrictions on painkiller to take effect

Aug 21, 2014

The federal government is finalizing new restrictions on hundreds of medicines containing hydrocodone, the highly addictive painkiller that has grown into the most widely prescribed drug in the U.S.

User comments